Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression
A widely used supplement for joint pain has been linked to a potentially concerning outcome in people with early cognitive problems.
Researchers at the University of Florida found that glucosamine use was associated with a greater likelihood that mild cognitive impairment would progress to dementia. Mild cognitive impairment, often shortened to MCI, describes measurable problems with memory or thinking that are greater than expected with normal aging but do not necessarily interfere substantially with everyday life.
Read the original report
Opens ScienceDaily in a new tab